---
title: "Artelo Biosciences May Offer Securities Up To $75 Million - SEC Filing"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285121277.md"
datetime: "2026-05-04T20:52:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285121277.md)
  - [en](https://longbridge.com/en/news/285121277.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285121277.md)
---

# Artelo Biosciences May Offer Securities Up To $75 Million - SEC Filing

May 4 (Reuters) - Artelo Biosciences Inc (ARTL.O) : \* ARTELO BIOSCIENCES INC - MAY OFFER SECURITIES UP TO $75 MILLION - SEC FILING Source text: Further company coverage: (ARTL.O)

### Related Stocks

- [ARTL.US](https://longbridge.com/en/quote/ARTL.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)

## Related News & Research

- [18:00 ETZYUS Life Sciences Expands U.S. Patent Portfolio with Second Pain Management Patent](https://longbridge.com/en/news/285274912.md)
- [Major Investor Makes Bold New Move on Seaport Therapeutics Stock](https://longbridge.com/en/news/285144653.md)
- [Madrigal's Q1 product revenue jumps 127%, net loss widens on higher costs](https://longbridge.com/en/news/285366810.md)
- [Xeris Biopharma Q1 product revenue jumps 43%, beats estimates](https://longbridge.com/en/news/285540653.md)
- [Royalty Pharma Q1 adjusted EBITDA misses analyst estimates](https://longbridge.com/en/news/285365538.md)